Mark P. Wu, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2033 Main St, Athol, MA 01331 Phone: 978-249-3511 Fax: 978-249-7666 |
News Archive
ChemoCentryx, Inc., today announced that it has identified a novel drug candidate targeting the chemoattractant receptor known as ChemR23. This investigational new drug, designated CCX832, is an orally-administered small molecule antagonist of ChemR23, an important player in inflammatory disease.
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Advocate Health Care-Illinois' largest health care provider-has renewed its multi-year, system-wide contract for Masimo SET pulse oximetry technology.
Women need to maintain good health years before they become pregnant. After all, healthy women are most likely to give birth to healthy babies.
Genetic alterations of the KRAS gene are some of the most common mutations in lung cancer patients, but unfortunately these patients have few effective treatment options.
A high-fat diet affects the molecular mechanism controlling the internal body clock that regulates metabolic functions in the liver, UC Irvine scientists have found. Disruption of these circadian rhythms may contribute to metabolic distress ailments, such as diabetes, obesity and high blood pressure.
› Verified 1 days ago